You are Here : DRL Q3 EBITDA seen up 103% to Rs 596 cr

Friday, 08:00

Pharmaceutial firm Dr Reddy's Laboratories is expected to report a profit after tax of Rs 425 crore in the third quarter of FY12, a massive growth of 55.5% as compared to Rs 273 crore in a year ago quarter.
NOV 22, 2017
12:56 PM

cnbc tv18 shows

All Shows


Half Time Report

As the name suggests, this show takes stock of the market internals at the half point of the day. On top of the hour, viewers get a recap of all the big moving stocks and experts offer trading strategies for the second half of the day. Hosted by Ekta Batra and Reema Tendulkar, the show covers the gl ... more »

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Follow us on
Available On